Should medication be increased if relapse occurs during tapering of methylprednisolone?
In general, if a relapse occurs during dose reduction of methylprednisolone, it is recommended to slightly increase the dosage under medical guidance. The specific analysis is as follows:
Methylprednisolone is a glucocorticoid used to treat various conditions, including rheumatic and rheumatoid diseases. Abruptly stopping this medication can easily lead to disease relapse; therefore, patients should gradually reduce the dosage to stabilize their condition and ensure therapeutic effectiveness. If a relapse occurs during dose tapering, it indicates that the disease has not been adequately controlled, and a small dose increase may be made under a doctor's instructions. Dose reduction of methylprednisolone should always follow the physician’s advice—gradually decreasing the amount helps minimize adverse effects while maintaining treatment efficacy and preventing relapse.
During methylprednisolone treatment, patients are advised to follow a diet low in salt, fat, and sugar, avoid smoking and alcohol, and refrain from consuming overly sweet or spicy, irritating foods. If any discomfort arises during treatment, patients should seek medical attention promptly and receive standardized care under a doctor's supervision.